Cook R - Search Results

1

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.

Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A; CONCOR-1 Study Group; Arnold DM. Bégin P, et al. Among authors: cook r. Nat Med. 2022 Jan;28(1):53-58. doi: 10.1038/s41591-021-01639-5. Epub 2022 Jan 10. Nat Med. 2022. PMID: 35013612 No abstract available.

2

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

Heddle NM, Cook RJ, Webert KE, Sigouin C, Rebulla P; Biomedical Excellence for Safer Transfusion Working Party of the International Society for Blood Transfusion. Heddle NM, et al. Transfusion. 2003 Jun;43(6):742-52. doi: 10.1046/j.1537-2995.2003.00418.x. Transfusion. 2003. PMID: 12757525

3

Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.

Rabbat CG, Cook DJ, Crowther MA, McDonald E, Clarke F, Meade MO, Lee KA, Cook RJ. Rabbat CG, et al. J Crit Care. 2005 Dec;20(4):357-63. doi: 10.1016/j.jcrc.2005.09.009. J Crit Care. 2005. PMID: 16310608 Clinical Trial.

4

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin.

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ. Arnold DM, et al. Anesth Analg. 2006 Mar;102(3):731-7. doi: 10.1213/01.ane.0000194954.64293.61. Anesth Analg. 2006. PMID: 16492820

5

A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia.

Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M, Rebulla P; BEST Collaborative (Biomedical Excellence for Safer Transfusion). Heddle NM, et al. Transfusion. 2006 Jun;46(6):903-11. doi: 10.1111/j.1537-2995.2006.00822.x. Transfusion. 2006. PMID: 16734806

6

Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.

Arnold DM, Crowther MA, Cook RJ, Sigouin C, Heddle NM, Molnar L, Cook DJ. Arnold DM, et al. Transfusion. 2006 Aug;46(8):1286-91. doi: 10.1111/j.1537-2995.2006.00892.x. Transfusion. 2006. PMID: 16934061

7

The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.

Webert K, Cook RJ, Sigouin CS, Rebulla P, Heddle NM. Webert K, et al. Haematologica. 2006 Nov;91(11):1530-7. Epub 2006 Oct 17. Haematologica. 2006. PMID: 17043016

8

A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms.

Webert KE, Cook RJ, Couban S, Carruthers J, Heddle NM. Webert KE, et al. Transfusion. 2006 Nov;46(11):1926-33. doi: 10.1111/j.1537-2995.2006.00999.x. Transfusion. 2006. PMID: 17076848 Clinical Trial.

9

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG. Arnold DM, et al. Ann Intern Med. 2007 Jan 2;146(1):25-33. doi: 10.7326/0003-4819-146-1-200701020-00006. Ann Intern Med. 2007. PMID: 17200219 Review.

10

A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.

Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, Lipton JH, Brandwein JM, Heddle NM. Webert KE, et al. Transfusion. 2008 Jan;48(1):81-91. doi: 10.1111/j.1537-2995.2007.01485.x. Epub 2007 Sep 24. Transfusion. 2008. PMID: 17894791 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,530 results

Search Page

Filters